<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01837758</url>
  </required_header>
  <id_info>
    <org_study_id>CVVH-Multiplate</org_study_id>
    <nct_id>NCT01837758</nct_id>
  </id_info>
  <brief_title>Monitoring Platelet Function During Continuous Hemodialysis</brief_title>
  <official_title>Changes in Platelet Function During Continuous Veno-venous Hemodialysis Using the Multiplate Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Goethe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Goethe University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is a description of changes in platelet function during continuous
      veno-venous hemodialysis or hemofiltration in patients on an intensive care unit using the
      Multiplate system.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ASPItest</measure>
    <time_frame>Baseline, 6, 12, 24 and 48 hours</time_frame>
    <description>Area under the aggregation curve (AUC) after platelet stimulation with arachidonic acid at baseline and 6, 12, 24 and 48 hours after the start of the continuous hemofiltration.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ADPtest</measure>
    <time_frame>Baseline, 6, 12, 24 and 48 hours</time_frame>
    <description>Area under the aggregation curve (AUC) after platelet stimulation with adenosine diphosphate at baseline and 6, 12, 24 and 48 hours after the start of the continuous hemofiltration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TRAPtest</measure>
    <time_frame>Baseline, 6, 12, 24, 48 hours</time_frame>
    <description>Area under the aggregation curve (AUC) after platelet stimulation with thrombin-receptor-activating peptide 6 (TRAP-6) at baseline and 6, 12, 24 and 48 hours after the start of the continuous hemofiltration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CT-INTEM</measure>
    <time_frame>Baseline, 6, 12, 24 and 48 hours</time_frame>
    <description>Clotting time (CT) in the intrinsically activated rotational thrombelastometry (ROTEM) recorded in seconds at baseline and 6, 12, 24 and 48 hours after the start of continuous veno-venous hemofiltration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MCF-INTEM</measure>
    <time_frame>Baseline, 6, 12, 24 and 48hours</time_frame>
    <description>Maximum clot firmness (MCF) in the intrinsically activated rotational thrombelastometry (ROTEM) recorded in millimeters at baseline and 6, 12, 24 and 48 hours after the start of continuous veno-venous hemofiltration.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Age</measure>
    <time_frame>Baseline</time_frame>
    <description>Age of the patient at the point of enrollment</description>
  </other_outcome>
  <other_outcome>
    <measure>Height</measure>
    <time_frame>Baseline</time_frame>
    <description>Height of the patient measured in centimeters.</description>
  </other_outcome>
  <other_outcome>
    <measure>Weight</measure>
    <time_frame>Baseline</time_frame>
    <description>Weight of the patient measured in kilograms.</description>
  </other_outcome>
  <other_outcome>
    <measure>Gender</measure>
    <time_frame>Baseline</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>ASA-Classification</measure>
    <time_frame>Baseline</time_frame>
    <description>The ASA-Classification will be determined preoperatively.</description>
  </other_outcome>
  <other_outcome>
    <measure>Antiaggregatory Premedication</measure>
    <time_frame>Baseline</time_frame>
    <description>Antiaggregatory medication taken prior to enrollment wil be recorded in the categories aspirin, clopidogrel, ticagrelor, cumarins and others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Dialysis filter</measure>
    <time_frame>Basline</time_frame>
    <description>The brand of filter used for the hemofiltration or hemodialysis will be registered.</description>
  </other_outcome>
  <other_outcome>
    <measure>Anticoagulation for hemofiltration</measure>
    <time_frame>Baseline</time_frame>
    <description>The anticoagulation used for hemofiltration will be recorded in the categories heparin and calcium citrate.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Platelet Function</condition>
  <arm_group>
    <arm_group_label>Dialysis</arm_group_label>
    <description>Platelet function will be documented during the first 48 hours of veno-venous hemofiltration using the Multiplate system.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in an intensive care unit with the need for a renal replacement therapy-
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Need for a continuous renal replacement therapy

          -  Platelet Count &gt;100.000/nl

        Exclusion Criteria:

          -  Pregnancy

          -  Age &lt;18 years

          -  Renal replacement therapy within the 7 days prior to enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Johann Wolfgang Goethe-University</name>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Daugirdas JT, Bernardo AA. Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia. Kidney Int. 2012 Jul;82(2):147-57. doi: 10.1038/ki.2012.130. Epub 2012 May 16. Review.</citation>
    <PMID>22592187</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2013</study_first_submitted>
  <study_first_submitted_qc>April 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2013</study_first_posted>
  <last_update_submitted>March 2, 2017</last_update_submitted>
  <last_update_submitted_qc>March 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Goethe University</investigator_affiliation>
    <investigator_full_name>Saskia Wand</investigator_full_name>
    <investigator_title>Dr. med Saskia Wand</investigator_title>
  </responsible_party>
  <keyword>Platelet function</keyword>
  <keyword>hemofiltration</keyword>
  <keyword>Multiplate</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

